Finnish biotechnology company Biohit Oyj has enabled its GastroPanel examination to be started from a whole blood sample without requiring an additional procedure.

The GastroPanel examination is a non-invasive blood test designed to detect Helicobacter pylori infection, characterised by a lack of acid in the stomach in asymptomatic and symptomatic patients. It can also detect risk of stomach cancer and vitamin B12 malabsorption.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The test gives information on the structure and function of the stomach mucosa and risks posed by the occurrence of a possible abnormal mucosa.

“When centrifugation and other sample processing steps can be omitted in the context of blood sampling, it is possible to further improve the patient safety and save cost.”

The test panel comprises four assays which are Pepsinogen I ELISA, Pepsinogen II ELISA, Gastrin-17 ELISA and Helicobacter pylori IgG ELISA.

Currently the GastroPanel test is performed by analysing a plasma sample submitted to laboratory which needs centrifugation of the whole blood after drawing the sample. Such sample processing steps to separate the plasma limits the usage of the test at doctor’s offices and private practices owing to its lack of centrifugation facilities.

However, following introduction of refinements, the test can now be conducted from a whole blood sample without centrifugation and transfer of the plasma into a tube with patient’s data label.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Biohit Oyj chief medical director Professor Kari Syrjänen said: “This update does not change the properties of the GastroPanel examination but makes it significantly easier to use especially among doctors who operate on a private practice.

“Now, when centrifugation and other sample processing steps can be omitted in the context of blood sampling, it is possible to further improve the patient safety and save cost.”

Labelled tubes carrying whole blood sample can be sent for analysis to clinical laboratories without centrifugation or other steps at the doctor’s office.